GO:1902109 negative regulation of mitochondrial membrane permeability involved in apoptotic process: Apoptosis Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902109 describes the biological process that prevents mitochondrial outer membrane permeabilization (MOMP) during apoptosis, thereby blocking release of cytochrome c and other pro-apoptotic factors.
• Key molecular players include BCL-2 family proteins (anti-apoptotic BCL-2, BCL-xL, MCL-1), the permeability transition pore component CypD, and metabolic regulators such as SIRT3 and hexokinase 2.
• Loss of this negative regulation leads to uncontrolled MOMP, caspase activation, and cell death, contributing to degenerative diseases, ischemia-reperfusion injury, and chemotherapy-induced toxicity.
• Experimental models for studying this process include CRISPR knockout of anti-apoptotic genes, point mutations in BCL-2 homology domains, and overexpression of prosurvival factors.
• The process is regulated by cellular energy status via AMPK, sirtuins, and hexokinase 2, linking metabolism to apoptotic threshold.
• Understanding GO:1902109 is critical for developing therapies that either promote cell death in cancer or prevent it in neurodegeneration and cardiotoxicity.
Description
The mitochondrial apoptotic pathway is governed by the balance between pro-apoptotic and anti-apoptotic signals that converge on the mitochondrial outer membrane. The Gene Ontology term GO:1902109, negative regulation of mitochondrial membrane permeability involved in apoptotic process, captures the cellular activities that preserve mitochondrial membrane integrity and prevent the release of apoptogenic factors such as cytochrome c. This process is essential for cell survival under stress and its dysregulation is a hallmark of numerous human diseases, including cancer, neurodegeneration, and ischemia-reperfusion injury. Researchers studying apoptosis, mitochondrial biology, and cell death mechanisms require a precise understanding of this term to design experiments and interpret data accurately. This article provides a comprehensive overview of GO:1902109, integrating authoritative QuickGO definitions with verified PubMed literature to describe its mechanisms, key genes, disease relevance, and state-of-the-art research methods.
negative regulation of mitochondrial membrane permeability involved in apoptotic process At A Glance
| GO ID | GO:1902109 |
|---|---|
| GO term | negative regulation of mitochondrial membrane permeability involved in apoptotic process |
| Ontology | biological_process |
| Synonym | mitochondrial membrane impermeability involved in apoptosis; negative regulation of transport across mitochondrial membrane involved in apoptotic process; mitochondrial membrane impermeabilization involved in apoptotic process |
| Major function | Prevents mitochondrial outer membrane permeabilization (MOMP) and subsequent cytochrome c release during apoptosis |
| Related processes | Apoptotic process, regulation of mitochondrial membrane permeability, intrinsic apoptotic signaling pathway |
| Key regulators | BCL-2 family proteins, cyclophilin D (CypD), hexokinase 2, SIRT3, AMPK |
| Disease relevance | Cancer, neurodegeneration, ischemia-reperfusion injury, chemotherapy-induced toxicity |
What Is GO:1902109?
GO:1902109 is defined as any negative regulation of mitochondrial membrane permeability that is involved in apoptotic process. In other words, it encompasses the biological activities that decrease the permeability of mitochondrial membranes, specifically in the context of apoptosis, thereby inhibiting the release of mitochondrial intermembrane space proteins that would otherwise trigger caspase activation and cell death.
Why Is negative regulation of mitochondrial membrane permeability involved in apoptotic process Important in Cell Biology?
GO:1902109 is critically important because it defines the cellular mechanisms that set the threshold for apoptosis. By maintaining mitochondrial membrane impermeability, cells can survive transient stress; however, when this negative regulation fails, uncontrolled MOMP leads to irreversible cell death. This process is central to development, tissue homeostasis, and the pathogenesis of diseases ranging from cancer to neurodegeneration. Understanding how this process is regulated offers therapeutic opportunities to either sensitize cancer cells to apoptosis or protect healthy cells from premature death.
• Determines cell fate by controlling the point of no return in intrinsic apoptosis.
• Dysregulation contributes to cancer cell survival and chemoresistance.
• Loss of negative regulation is implicated in neurodegeneration and ischemia-reperfusion injury.
• Metabolic regulators such as SIRT3 and AMPK modulate this process, linking energy status to cell survival.
• Hexokinase 2 and its regulation by miRNAs influence apoptotic sensitivity in cardiomyocytes.
• Cyclophilin D-mediated permeability transition is a key target in titanium ion-induced osteoblast injury.
• The process is exploited by viruses and cancer cells to evade apoptosis.
• Experimental modulation of this process is essential for drug discovery and toxicity testing.
• CRISPR-based models enable precise dissection of gene function in this pathway.
• Biomarkers of mitochondrial membrane integrity are emerging as diagnostic and prognostic tools.
What Happens During negative regulation of mitochondrial membrane permeability involved in apoptotic process?
Maintenance of Mitochondrial Outer Membrane Integrity
In simple terms: The cell actively keeps the mitochondrial outer membrane sealed to prevent leakage of death-inducing proteins.
Under normal conditions, anti-apoptotic BCL-2 family proteins such as BCL-2, BCL-xL, and MCL-1 bind to and inhibit the pro-apoptotic effectors BAX and BAK, preventing their oligomerization and pore formation in the mitochondrial outer membrane. This negative regulation ensures that cytochrome c and other intermembrane space proteins remain sequestered, blocking caspase activation. Metabolic signals, including those mediated by hexokinase 2, also contribute to maintaining membrane impermeability by interacting with voltage-dependent anion channels (VDAC) and modulating mitochondrial energetics.
Inhibition of Permeability Transition Pore Opening
In simple terms: The cell prevents the opening of a large pore in the mitochondrial membrane that would otherwise cause swelling and rupture.
The mitochondrial permeability transition pore (mPTP) is a high-conductance channel whose opening leads to mitochondrial swelling and rupture. Negative regulation of mPTP opening involves cyclophilin D (CypD, encoded by PPIF), a peptidyl-prolyl isomerase that sensitizes the pore to opening; its inhibition or deletion confers resistance to permeability transition. Additionally, adenine nucleotide translocase (ANT) isoforms modulate mPTP activity in response to cellular stress, and their regulation is critical for preventing degenerative cell death. SIRT3, a mitochondrial deacetylase, also protects against mPTP opening by deacetylating CypD and other targets.
Metabolic Checkpoints and AMPK Signaling
In simple terms: The cell's energy sensors can strengthen the mitochondrial barrier when energy is low.
AMP-activated protein kinase (AMPK) acts as a metabolic checkpoint that promotes cell survival under glucose deprivation by phosphorylating targets that maintain mitochondrial function. Sestrin2-AMPK activation protects mitochondrial function against glucose deprivation-induced cytotoxicity, partly by preserving membrane integrity. Similarly, SIRT3-mediated deacetylation enhances mitochondrial antioxidant defenses and stabilizes the membrane, reducing apoptotic susceptibility. These pathways link nutrient availability to the regulation of mitochondrial membrane permeability.
Regulation by BCL-2 Family Interactions
In simple terms: A balance between pro-death and pro-survival proteins decides whether the mitochondrial membrane stays intact.
The BCL-2 family is central to GO:1902109. Anti-apoptotic members (BCL-2, BCL-xL, MCL-1, BCL-W, A1) sequester pro-apoptotic BH3-only proteins (e.g., BIM, PUMA, tBID) and prevent BAX/BAK activation. Post-translational modifications, such as phosphorylation of BCL-2, can enhance or diminish its protective function. In T-leukemia cells, ECRG4 acts as a negative regulator of caspase-8-mediated apoptosis, indirectly influencing mitochondrial membrane permeability. Thus, the stoichiometry and interaction dynamics of BCL-2 family proteins set the apoptotic threshold.
Role of Lysosomal-Mitochondrial Crosstalk
In simple terms: Signals from lysosomes can influence whether mitochondria commit to apoptosis.
Lysosomal membrane permeabilization can trigger mitochondrial membrane permeabilization through cathepsins and other mediators. In zoledronic acid-induced apoptosis of human follicular lymphoma cells, the lysosomal-mitochondrial axis plays a key role; negative regulation of mitochondrial membrane permeability can be overcome by lysosomal signals, leading to MOMP and cell death. This crosstalk highlights that GO:1902109 is not isolated but integrated with other organelles.
Key Genes Involved in GO:1902109 negative regulation of mitochondrial membrane permeability involved in apoptotic process
The following genes and proteins are key players in the negative regulation of mitochondrial membrane permeability involved in apoptotic process, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BCL2 | Anti-apoptotic; binds BAX/BAK to prevent MOMP | Overexpression protects against apoptosis; target in cancer therapy |
| BCL2L1 (BCL-xL) | Anti-apoptotic; inhibits BAX/BAK and mPTP opening | Knockout leads to increased apoptosis; studied in neurodegeneration |
| MCL1 | Anti-apoptotic; sequesters BH3-only proteins | Frequently amplified in cancers; target for inhibitors |
| BAX | Pro-apoptotic; forms pores upon activation | Knockout confers resistance to apoptosis; point mutations alter function |
| BAK | Pro-apoptotic; oligomerizes to permeabilize MOM | Double knockout with BAX blocks MOMP |
| PPIF (CypD) | Regulates mPTP opening; sensitizes to permeability transition | Inhibition protects against ischemia-reperfusion injury |
| SIRT3 | Mitochondrial deacetylase; protects membrane integrity | Overexpression reduces oxidative stress-induced apoptosis |
| HK2 | Hexokinase 2; binds VDAC and maintains membrane impermeability | Knockdown increases apoptosis; target in cancer metabolism |
| ECRG4 | Negative regulator of caspase-8-mediated apoptosis | Loss promotes apoptosis in T-leukemia cells |
| SESN2 (Sestrin2) | Activates AMPK; protects mitochondrial function | Overexpression protects against glucose deprivation |
| PRKAA1/2 (AMPK) | Energy sensor; promotes survival under stress | Activation preserves mitochondrial membrane integrity |
| ANT (SLC25A4-6) | Adenine nucleotide translocase; modulates mPTP | Isoform-specific roles in degenerative cell death |
| VDAC1-3 | Voltage-dependent anion channels; interact with HK2 and BCL-2 family | Regulate metabolite exchange and apoptosis |
| BID | BH3-only protein; links death receptors to mitochondria | Cleavage by caspase-8 triggers MOMP |
| BIM (BCL2L11) | BH3-only protein; activates BAX/BAK | Knockout reduces apoptosis in lymphocytes |
| PUMA (BBC3) | BH3-only protein; binds anti-apoptotic BCL-2 proteins | p53 target; mediates DNA damage-induced apoptosis |
| NOXA (PMAIP1) | BH3-only protein; inhibits MCL-1 and A1 | Regulates sensitivity to chemotherapy |
How Is negative regulation of mitochondrial membrane permeability involved in apoptotic process Regulated?
The negative regulation of mitochondrial membrane permeability involved in apoptotic process is tightly controlled by multiple signaling pathways. Metabolic sensors such as AMPK and SIRT3 integrate energy status and oxidative stress to modulate the apoptotic threshold. Hexokinase 2, whose expression is regulated by miRNAs, binds to VDAC and maintains membrane impermeability; neutralization of HK2-targeting miRNA attenuates oxidative stress-induced cardiomyocyte apoptosis. Additionally, BCL-2 family proteins are regulated by transcriptional (e.g., p53) and post-translational mechanisms (phosphorylation, ubiquitination) that fine-tune their activity. The lysosomal-mitochondrial axis also influences this process through cathepsin release.
negative regulation of mitochondrial membrane permeability involved in apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BCL2 | Cancer (lymphoma, leukemia) | Knockout or overexpression in cancer cell lines; xenograft models |
| PPIF (CypD) | Ischemia-reperfusion injury, osteoblast injury | Knockout mice; titanium ion-treated MC3T3-E1 cells |
| SIRT3 | Metabolic disorders, granulosa cell dysfunction | Overexpression in bovine granulosa cells; knockout mice |
| HK2 | Cardiomyocyte apoptosis, cancer metabolism | miRNA neutralization in cardiomyocytes; knockout cancer cells |
| ECRG4 | T-leukemia | Knockdown or overexpression in Jurkat cells |
Cancer
In many cancers, overexpression of anti-apoptotic BCL-2 family proteins (e.g., BCL-2, MCL-1) enhances negative regulation of mitochondrial membrane permeability, allowing tumor cells to evade apoptosis and resist chemotherapy. ECRG4, a negative regulator of caspase-8-mediated apoptosis, is downregulated in some T-leukemias, suggesting that loss of this regulation can also contribute to leukemogenesis. Targeting these survival mechanisms with BH3 mimetics is a major therapeutic strategy.
Neurodegeneration
In neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, aberrant mitochondrial membrane permeabilization contributes to neuronal loss. Impaired negative regulation, often due to oxidative stress and metabolic dysfunction, leads to cytochrome c release and caspase activation. Mitochondrial dysfunction is a multifaceted player in autism spectrum disorder, where altered apoptotic regulation may affect neuronal development.
Ischemia-Reperfusion Injury and Cardiotoxicity
During ischemia-reperfusion, opening of the mitochondrial permeability transition pore (mPTP) triggers cell death. Negative regulation of mPTP opening, mediated by CypD inhibition or SIRT3 activation, is cardioprotective. In cardiomyocytes, hexokinase 2 and its regulatory miRNAs modulate oxidative stress-induced apoptosis, highlighting therapeutic targets.
Bone and Metabolic Disorders
Titanium ions released from implants induce osteoblast injury via CypD-mediated mitochondrial dysfunction, overriding negative regulation of membrane permeability and causing apoptosis. Similarly, in bovine granulosa cells, β-hydroxybutyric acid-induced mitochondrial dysfunction is alleviated by SIRT3 regulation, linking metabolic status to fertility.
From negative regulation of mitochondrial membrane permeability involved in apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of BCL-2 enhance MOMP? | BCL2 knockout cell lines (e.g., HeLa, MEFs) |
| Does CypD inhibition protect against mPTP opening? | PPIF knockout mice or cells treated with cyclosporin A |
| How does SIRT3 deacetylation affect membrane integrity? | SIRT3 overexpression or knockout in granulosa cells |
| Can HK2 modulation alter apoptotic threshold? | HK2 knockdown or miRNA mimic in cardiomyocytes |
| What is the role of ECRG4 in caspase-8-mediated apoptosis? | ECRG4 knockdown in T-leukemia cells |
| Does AMPK activation preserve mitochondrial function? | Sestrin2 overexpression or AMPK activator in glucose-deprived cells |
How to Study the negative regulation of mitochondrial membrane permeability involved in apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cytochrome c release assay | MOMP induction | Apoptosis studies in cell lines |
| JC-1 staining | Mitochondrial membrane potential | High-throughput screening for apoptosis modulators |
| Mitochondrial swelling assay | mPTP opening | Ischemia-reperfusion models |
| Ribo-seq | Translational efficiency of anti-apoptotic genes | Stress response studies |
| CRISPR knockout screen | Genes regulating membrane permeability | Functional genomics |
| FRET caspase biosensor | Caspase activation dynamics | Live-cell imaging |
| Annexin V/PI flow cytometry | Phosphatidylserine externalization and cell death | Drug toxicity testing |
| Co-immunoprecipitation | BCL-2 family interactions | Mechanistic studies |
Measuring Mitochondrial Membrane Permeability
Mitochondrial outer membrane permeabilization (MOMP) can be assessed by cytochrome c release assays, live-cell imaging of fluorescently tagged cytochrome c, or flow cytometry using dyes that detect mitochondrial membrane potential (e.g., TMRE, JC-1). Permeability transition pore opening is measured by mitochondrial swelling assays or calcein-cobalt quenching.
Proteomic and Genomic Approaches
Proteomics can identify changes in BCL-2 family interactions and post-translational modifications. RNA-seq and Ribo-seq reveal transcriptional and translational responses of anti-apoptotic genes under stress. CRISPR screens can systematically identify genes that regulate mitochondrial membrane permeability.
Live-Cell Imaging and Biosensors
Genetically encoded FRET biosensors for caspase activation and mitochondrial membrane potential allow real-time monitoring of apoptosis in single cells. Fluorescent proteins targeted to mitochondria (e.g., mito-GFP) enable visualization of morphological changes during MOMP.
Functional Assays for Apoptosis
Apoptosis is quantified by Annexin V/PI staining, TUNEL assays, and caspase-3/7 activity assays. These methods are used to determine whether genetic or pharmacological interventions alter the negative regulation of mitochondrial membrane permeability.
How CRISPR Can Be Used to Study GO:1902109 negative regulation of mitochondrial membrane permeability involved in apoptotic process
Knockout
CRISPR knockout of anti-apoptotic genes such as BCL2, MCL1, or PPIF can be used to test their role in maintaining mitochondrial membrane impermeability. For example, PPIF knockout cells are resistant to mPTP opening and apoptosis induced by calcium overload. Knockout of BAX and BAK abolishes MOMP, providing a tool to study the negative regulation.
Point Mutation
Point mutations in BCL-2 homology domains (e.g., BH3 domain) can disrupt interactions with pro-apoptotic proteins, converting anti-apoptotic BCL-2 into a sensitizer. Such mutations help map the residues critical for negative regulation of membrane permeability. Similarly, mutations in CypD's isomerase active site can dissect its role in mPTP regulation.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci of BCL-2 family genes allows real-time tracking of protein localization and turnover during apoptosis. Knock-in of disease-associated mutations (e.g., in SIRT3) can model altered mitochondrial membrane regulation.
Overexpression
Overexpression of anti-apoptotic genes such as BCL2, BCL2L1, or SIRT3 protects cells from apoptosis and enhances negative regulation of mitochondrial membrane permeability. This approach is used to study cytoprotection in models of ischemia-reperfusion injury and neurodegeneration.
How EDITGENE Supports negative regulation of mitochondrial membrane permeability involved in apoptotic process Research
Researchers studying negative regulation of mitochondrial membrane permeability involved in apoptotic process-related genes often need to determine whether a candidate gene is causally involved in maintaining mitochondrial integrity or whether its modulation alters apoptotic sensitivity. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of mitochondrial membrane permeability involved in apoptotic process research.
Frequently Asked Questions About negative regulation of mitochondrial membrane permeability involved in apoptotic process
What is GO:1902109?
GO:1902109 is a Gene Ontology term for the biological process 'negative regulation of mitochondrial membrane permeability involved in apoptotic process', which prevents mitochondrial outer membrane permeabilization during apoptosis.
What genes are involved in negative regulation of mitochondrial membrane permeability?
Key genes include BCL2, BCL2L1, MCL1, PPIF (CypD), SIRT3, HK2, and SESN2, among others.
How is mitochondrial membrane permeability regulated during apoptosis?
It is regulated by the balance of BCL-2 family proteins, metabolic sensors like AMPK and SIRT3, and the permeability transition pore component CypD.
What diseases are associated with dysregulated mitochondrial membrane permeability?
Cancer, neurodegeneration, ischemia-reperfusion injury, and chemotherapy-induced cardiotoxicity are linked to altered regulation of this process.
What experimental models are used to study GO:1902109?
Common models include CRISPR knockout cell lines, point mutant knock-ins, overexpression systems, and live-cell imaging with fluorescent biosensors.
How can CRISPR be used to study negative regulation of mitochondrial membrane permeability?
CRISPR knockout of anti-apoptotic genes, point mutations in BCL-2 homology domains, and knock-in of reporters allow precise dissection of gene function in this pathway.
What is the role of CypD in mitochondrial membrane permeability?
CypD (PPIF) sensitizes the mitochondrial permeability transition pore to opening; its inhibition or knockout enhances negative regulation and protects against cell death.
How does SIRT3 affect mitochondrial membrane integrity?
SIRT3 deacetylates mitochondrial proteins, including CypD, and enhances antioxidant defenses, thereby preserving membrane integrity and reducing apoptosis.
What methods measure mitochondrial membrane permeability?
Cytochrome c release assays, JC-1 staining, mitochondrial swelling assays, and live-cell imaging with FRET biosensors are commonly used.
Why is negative regulation of mitochondrial membrane permeability important in cancer?
Cancer cells often upregulate anti-apoptotic proteins to maintain membrane impermeability, evading apoptosis and resisting therapy; targeting this process is a therapeutic strategy.
Conclusion
GO:1902109, negative regulation of mitochondrial membrane permeability involved in apoptotic process, is a fundamental biological process that governs cell survival by preventing mitochondrial outer membrane permeabilization. Its dysregulation is implicated in a wide range of diseases, from cancer to neurodegeneration. Understanding the molecular players and regulatory mechanisms is essential for developing targeted therapies. EDITGENE offers advanced CRISPR services to facilitate research in this field, enabling precise genetic models and functional screens.
References
- 1. Khaliulin I et al.. 2025. The multifaceted role of mitochondria in autism spectrum disorder.. Mol Psychiatry 30(2):629-650 PMID: 39223276
- 2. Mao Y et al.. 2023. CypD-mediated mitochondrial dysfunction contributes to titanium ion-induced MC3T3-E1 cell injury.. Biochem Biophys Res Commun 644:15-24 PMID: 36621148
- 3. Zhao S et al.. 2023. Sirtuin 3 regulation: a target to alleviate β-hydroxybutyric acid-induced mitochondrial dysfunction in bovine granulosa cells.. J Anim Sci Biotechnol 14(1):18 PMID: 36788581
- 4. Liu Y et al.. 2013. Adenine nucleotide translocase, mitochondrial stress, and degenerative cell death.. Oxid Med Cell Longev 2013:146860 PMID: 23970947
- 5. Mitrofan LM et al.. 2010. Lysosomal-mitochondrial axis in zoledronic acid-induced apoptosis in human follicular lymphoma cells.. J Biol Chem 285(3):1967-79 PMID: 19875454
- 6. Matsuzaki J et al.. 2012. ECRG4 is a negative regulator of caspase-8-mediated apoptosis in human T-leukemia cells.. Carcinogenesis 33(5):996-1003 PMID: 22411956
- 7. Kim KW et al.. 2021. Neutralization of hexokinase 2-targeting miRNA attenuates the oxidative stress-induced cardiomyocyte apoptosis.. Clin Hemorheol Microcirc 78(1):57-68 PMID: 33523042
- 8. Seo K et al.. 2015. Sestrin2-AMPK activation protects mitochondrial function against glucose deprivation-induced cytotoxicity.. Cell Signal 27(7):1533-43 PMID: 25778901
